Miller Howard Investments Inc. NY lessened its stake in CME Group Inc. (NASDAQ:CME) by 3.0% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 526,754 shares of the financial services provider’s stock after selling 16,359 shares during the quarter. CME Group comprises approximately 1.5% of Miller Howard Investments Inc. NY’s holdings, making the stock its 26th biggest holding. Miller Howard Investments Inc. NY owned approximately 0.15% of CME Group worth $71,470,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. Schwab Charles Investment Management Inc. lifted its holdings in shares of CME Group by 6.6% during the 1st quarter. Schwab Charles Investment Management Inc. now owns 1,503,339 shares of the financial services provider’s stock valued at $178,597,000 after acquiring an additional 93,388 shares in the last quarter. BlueMar Capital Management LLC acquired a new position in shares of CME Group during the 1st quarter valued at $1,824,000. Oppenheimer Asset Management Inc. acquired a new position in shares of CME Group during the 1st quarter valued at $3,342,000. Two Sigma Securities LLC lifted its holdings in shares of CME Group by 5.4% during the 1st quarter. Two Sigma Securities LLC now owns 49,101 shares of the financial services provider’s stock valued at $5,833,000 after acquiring an additional 2,508 shares in the last quarter. Finally, Level Four Advisory Services LLC lifted its holdings in shares of CME Group by 18.4% during the 1st quarter. Level Four Advisory Services LLC now owns 4,010 shares of the financial services provider’s stock valued at $471,000 after acquiring an additional 623 shares in the last quarter. Institutional investors own 82.79% of the company’s stock.

In other CME Group news, President Bryan T. Durkin sold 9,200 shares of the stock in a transaction on Tuesday, August 8th. The shares were sold at an average price of $125.13, for a total value of $1,151,196.00. Following the completion of the sale, the president now directly owns 70,938 shares of the company’s stock, valued at approximately $8,876,471.94. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, COO Julie Holzrichter sold 11,915 shares of the stock in a transaction on Monday, August 7th. The shares were sold at an average price of $125.67, for a total transaction of $1,497,358.05. Following the completion of the sale, the chief operating officer now directly owns 43,657 shares of the company’s stock, valued at $5,486,375.19. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 27,479 shares of company stock valued at $3,498,921. 0.57% of the stock is owned by insiders.

Several equities analysts recently weighed in on the stock. Barclays PLC lifted their target price on shares of CME Group from $139.00 to $149.00 and gave the company an “overweight” rating in a report on Tuesday, October 10th. Wells Fargo & Company lifted their target price on shares of CME Group from $130.00 to $145.00 and gave the company a “market perform” rating in a report on Wednesday, October 4th. Royal Bank Of Canada lifted their target price on shares of CME Group from $135.00 to $147.00 and gave the company an “outperform” rating in a report on Monday, October 16th. Citigroup Inc. lifted their target price on shares of CME Group from $138.00 to $155.00 and gave the company a “buy” rating in a report on Thursday, October 19th. Finally, BidaskClub lowered shares of CME Group from a “strong-buy” rating to a “buy” rating in a report on Wednesday, October 18th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and six have assigned a buy rating to the stock. The company currently has an average rating of “Hold” and an average price target of $138.89.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Thursday, October 26th. The financial services provider reported $1.19 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.16 by $0.03. The business had revenue of $890.80 million during the quarter, compared to the consensus estimate of $890.22 million. CME Group had a net margin of 40.94% and a return on equity of 7.89%. CME Group’s quarterly revenue was up 5.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.05 EPS.

ILLEGAL ACTIVITY NOTICE: “CME Group Inc. (CME) Shares Sold by Miller Howard Investments Inc. NY” was published by Watch List News and is the property of of Watch List News. If you are reading this piece on another publication, it was copied illegally and republished in violation of U.S. & international trademark and copyright legislation. The legal version of this piece can be viewed at https://www.watchlistnews.com/cme-group-inc-cme-shares-sold-by-miller-howard-investments-inc-ny/1673824.html.

CME Group Company Profile

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.